Pub. Date : 2019 Nov 4
PMID : 31689961
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | A clinical phase III trial using MDM2/X inhibitors, idasanutlin (RG7388) combined with cytarabine, is being performed involving relapse/refractory acute myeloid leukemia patients. | RG7388 | MDM2 proto-oncogene | Homo sapiens |